PUBLISHER: The Business Research Company | PRODUCT CODE: 1751178
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751178
Western blotting is a laboratory technique used to detect and analyze specific proteins within a sample. The process involves separating proteins via gel electrophoresis, transferring them onto a membrane, and using antibodies to identify the target protein. This technique is essential for examining protein expression, molecular weight, and post-translational modifications.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The western blotting market primarily comprises instruments and consumables. Western blotting instruments are specialized laboratory devices designed to carry out the Western blot technique for detecting and analyzing specific proteins in samples. Applications of this technique span scientific research, medical diagnostics, agriculture, food and beverage industries, among others. The end-users include academic and research institutions, pharmaceutical and biotechnology companies, diagnostic centers, and additional sectors.
The western blotting market research report is one of a series of new reports from The Business Research Company that provides western blotting market statistics, including western blotting industry global market size, regional shares, competitors with a western blotting market share, detailed western blotting market segments, market trends and opportunities, and any further data you may need to thrive in the western blotting industry. This western blotting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The western blotting market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to the increasing demand for protein detection, the rising prevalence of chronic diseases, a growing incidence of brain disorders, expanding healthcare needs, and the heightened need for a reliable method of protein identification.
The western blotting market size is expected to see strong growth in the next few years. It will grow to $2.00 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increased investments in healthcare infrastructure, a growing number of Western blot tests, a rising prevalence of cardiovascular diseases, higher demand for personalized medicine, and the expanding use of electrophoresis blotting systems. Key trends expected during the forecast period include technological advancements, biomarker discovery, the advancement of personalized medicine, the emergence of alternative techniques, and the implementation of quality control measures.
The growing prevalence of human immunodeficiency virus (HIV) is anticipated to drive the expansion of the western blotting market. HIV is a virus that compromises the immune system, reducing the body's ability to combat infections and illnesses. The increasing incidence of HIV is primarily linked to insufficient awareness and education regarding preventive measures, which raises the risk of transmission. Western blotting is a key diagnostic method used for confirming HIV infections, playing a critical role in early detection and timely treatment, which are vital for effective disease management. For example, in October 2024, Gov.UK, a UK government agency, reported 6,402 HIV diagnoses in the UK (excluding Northern Ireland) in 2023 an increase of 46% from 4,379 cases in 2022. Consequently, the rising number of HIV cases is contributing to the growth of the western blotting market.
Leading companies in the western blotting market are prioritizing the development of cutting-edge imaging systems, such as complementary metal-oxide-semiconductor (CMOS) digital imaging and stain-free imaging technologies to improve image clarity, precision in protein quantification, and overall research throughput. CMOS digital imaging captures gel and blot images with high sensitivity using advanced sensors, while stain-free imaging technology allows total protein normalization without additional steps such as probing or stripping, streamlining the western blot process. For instance, in July 2024, Bio-Rad, a US-based biotech firm, introduced the ChemiDoc Go Imaging System. This compact imaging system integrates CMOS digital and stain-free imaging technologies, enhancing sensitivity, accuracy, and efficiency in western blotting and gel imaging. It is particularly suited for protein quantification and quality control in life science research.
In September 2024, Leinco Technologies Inc., a US-based biotechnology firm, acquired QED Biosciences for an undisclosed sum. This acquisition is intended to expand Leinco's catalog of high-quality antibodies, reagents, and development services, thereby strengthening its standing in the global antibody market. It also enhances the company's capabilities in supporting research and in vitro diagnostics (IVD), encouraging innovation and delivering greater value to scientists and healthcare professionals. QED Biosciences, also based in the US, specializes in antibodies and recombinant proteins commonly used in western blotting.
Major players in the western blotting market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, GE Healthcare, EMD Millipore, PerkinElmer Inc., Bio-Rad Laboratories, GeneTex Inc., GenScript Biotech, Abcam plc, Promega Corporation, Takara Bio Inc., Cell Signaling Technology, Proteintech Group Inc., Cygnus Technologies, Santa Cruz Biotechnology, Abnova Corporation, Azure Biosystems Inc., Leinco Technologies Inc., LI-COR Biosciences GmbH, Novus Biologicals LLC.
North America was the largest region in the western blotting market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in western blotting report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the western blotting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The western blotting market consists of revenues earned by entities by providing services such as sample preparation, custom assay development, equipment maintenance, antibody probing, and antibody probing. The market value includes the value of related goods sold by the service provider or included within the service offering. The western blotting market also includes sales of transfer membranes, protein markers, chemiluminescent substrates, power supplies, and secondary antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Western Blotting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on western blotting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for western blotting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The western blotting market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.